More on BMSN

- Summary
- Chart
- Profile
- Historical

Financials

Income Statement
Balance Sheet
Cash Flow Statement

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BMSN Balance Sheet

Click line-items for a historical chart and %
Cash 142.09K
Prepaid Expenses
Employee Receivable
Total Current Assets 187.42K
Property and Equipment (net of accumulated depreciation)
Other Assets 84.87K
Investment in Entest
Total Assets 272.28K
Accounts Payable 289.74K
Notes Payable
Accrued Payroll 970.59K
Accrued Payroll Taxes 43.34K
Accrued Interest
Accrued Expenses
Convertible Note Payable
Due to Affiliate 1K
Current portion, note payable to affiliated party
Total Current Liabilities 2.35M
Total Liabilities 2.45M
Preferred Stock ($.0001 par value) 20,000,000 shares authorized; 1,963,821 issues and outstanding as of June 30, 2011 and September 30, 2010 respectively 207
Series B Preferred Shares ($.0001 par value) 2,000,000 shares authorized; 725,409 issues and outstanding as of June 30, 2011 and September 30, 2010
Common Stock ($.0001 par value 80,000,000 shares authorized; 72,189,747 and 70,404,033 shares issued and outstanding as of June 30, 2011 and September 30 , 2010 respectively 574.64K
Contributed Capital
Retained Earnings (Deficit) accumulated during the development stage -37.52M
Equity in Earnings (Losses) of Entest BioMedical, Inc.
Deficit attributable to noncontrolling interest in subsidiary
Total Stockholders' Equity (Deficit)
Total Liabilities and Shareholders' Equity (Deficit) 272.28K